06/02/2025
5:05 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/27/2025
5:56 AM | Novartis (Filed by)
Regulus Therapeutics Inc. (Subject)
| Form SC TO-T | |
05/01/2025
4:00 PM | Novartis (Filed by)
Regulus Therapeutics Inc. (Subject)
| Form SC TO-C | |
04/30/2025
4:00 PM | Novartis (Filed by)
Regulus Therapeutics Inc. (Subject)
| Form SC TO-C | |
04/29/2025
5:01 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2025
8:35 PM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2025
1:01 PM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025
6:07 AM | Novartis (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
01/31/2025
6:12 AM | Novartis (Filer)
| Form IRANNOTICE | |
01/31/2025
6:14 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025
6:16 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for NVS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Novartis and its competitors with MarketBeat's FREE daily newsletter. |
12/30/2024
5:05 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/25/2024
9:20 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024
5:20 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
3:38 PM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/17/2024
4:08 PM | Novartis (Filer)
Novartis Capital CORP (Filer)
| Form 424B5 | |
09/17/2024
1:05 PM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
4:12 PM | Novartis (Subject)
| Form FWP | |
09/16/2024
7:44 AM | Novartis (Filer)
Novartis Capital CORP (Filer)
| Form 424B5 | |
09/16/2024
7:12 AM | Novartis (Filer)
Novartis Capital CORP (Filer)
| Form F-3ASR | |
08/15/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC 13D/A | |
08/13/2024
3:31 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
08/12/2024
2:30 PM | Kowalski Robert William (Reporting)
Novartis (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
7:12 PM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
08/02/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
08/01/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/31/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/30/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/29/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/18/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/18/2024
5:09 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/05/2024
5:02 AM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T | |
06/21/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC 13D/A | |
06/20/2024
2:38 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-C | |
06/17/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC 13D/A | |
